June marks Scleroderma Awareness Month, a crucial period dedicated to raising awareness about this challenging autoimmune disease and highlighting its profound impact on countless lives. At MLM Medical Labs, we are steadfastly committed to advancing research and supporting therapeutic initiatives to combat systemic sclerosis (SSc), a severe manifestation of scleroderma.
Innovating for a Brighter Future in Scleroderma Research Read More »
Digital Pathology represents a revolutionary convergence of tissue research and technology, catalyzing transformative changes in the field of pathology research. This innovative approach to pathology holds immense potential, offering a myriad of benefits and paving the way for exciting future possibilities in healthcare research.
Here at MLM Medical Labs, we’re at the forefront of this groundbreaking research endeavor. Our dedicated team is committed to unraveling the intricate mechanisms underlying obesity-related diseases and evaluating the therapeutic efficacy of Ozempic type drugs through our advanced preclinical models and comprehensive ex-vivo assessments.
MLM Medical Labs is passionate about the transformative potential of cell and gene therapy in revolutionizing healthcare
Clinical Lab Services for Cell and Gene Therapy Research Read More »
Flow cytometry is crucial in canine research, diagnostics and support for drug development. MLM’s canine flow services offer validated immune panel required to understand the canine immune system.
Canine Flow Cytometry Services Read More »
Recent research highlights the crucial role of PD-L1 in cancer immunotherapy, emphasizing its significance as a predictive biomarker for treatment response and patient prognosis. MLM Medical Lab’s capabilities in exploring PD-L1 expression dynamics facilitate current research efforts and make us a great partner for oncology projects.
Featured Histology Image of the Month : February Read More »
MLM Medical Labs stands in solidarity with survivors, researchers, and healthcare heroes who contribute to the fight against this life-threatening condition.
February 11-17: Sepsis Survivor Week Read More »
MLM’s library of nearly 1000 validated assays were developed for diabetes studies – a crucial cretieria for selecting the right Central Lab in metabolic-related clinical trials.
Considerations for Conducting Clinical Studies on Metabolic Conditions Read More »
We are thrilled to announce the launch of our newly optimized IPF (Idiopathic Pulmonary Fibrosis) preclinical disease model. This model release is positioned to expand research opportunities in the fight against lung disease, providing researchers with an advanced tool to unlock new insights and accelerate the quest for effective treatments. Most remarkable about this optimization
We are extremely excited to announce the successful validation of the MC903 Atopic Dermatitis Model. This preclinical model, the 62nd in MLM’s growing lineup of validated models, provides an ideal solution for companies involved in translational and preclinical research in the field of atopic dermatitis. Atopic dermatitis, a prevalent chronic inflammatory skin condition, presents significant
